BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 24630633)

  • 1. [Peritoneal pseudomyxoma: an overview emphasizing pathological assessment and therapeutic strategies].
    Dartigues P; Isaac S; Villeneuve L; Glehen O; Capovilla M; Chevallier A; Croce S; Kaci R; Lang-Averous G; Laverriere MH; Leroux-Broussier A; Mery É; Poizat F; Valmary-Degano S; Verriele-Beurrier V; Gilly FN; Bibeau F
    Ann Pathol; 2014 Feb; 34(1):14-25. PubMed ID: 24630633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.
    Yan H; Pestieau SR; Shmookler BM; Sugarbaker PH
    Mod Pathol; 2001 Mar; 14(3):164-71. PubMed ID: 11266521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of clinical and pathological characteristics in 48 women with pseudomyxoma peritonei].
    Lu YY; Guo AT; Liu AJ; Shi HY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):595-601. PubMed ID: 24199925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucinous neoplasms of the appendix and peritoneum.
    Panarelli NC; Yantiss RK
    Arch Pathol Lab Med; 2011 Oct; 135(10):1261-8. PubMed ID: 21970481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomyxoma Peritonei.
    Bartoška P; Antoš F; Vítek P; Marx J; Kopic J; Holečková P
    Klin Onkol; 2019; 32(5):329-332. PubMed ID: 31610663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process.
    Carr NJ; Cecil TD; Mohamed F; Sobin LH; Sugarbaker PH; González-Moreno S; Taflampas P; Chapman S; Moran BJ;
    Am J Surg Pathol; 2016 Jan; 40(1):14-26. PubMed ID: 26492181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomyxoma peritonei: review on a cluster of peritoneal mucinous diseases.
    Jacquemin G; Laloux P
    Acta Chir Belg; 2005 Apr; 105(2):127-33. PubMed ID: 15906901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current concepts in pseudomyxoma peritonei.
    Carr NJ
    Ann Pathol; 2014 Feb; 34(1):9-13. PubMed ID: 24630632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual tumors of the appendix and pseudomyxoma peritonei.
    Carr NJ; Sobin LH
    Semin Diagn Pathol; 1996 Nov; 13(4):314-25. PubMed ID: 8946609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The coexistence of low-grade mucinous neoplasms of the appendix and appendiceal diverticula: a possible role in the pathogenesis of pseudomyxoma peritonei.
    Lamps LW; Gray GF; Dilday BR; Washington MK
    Mod Pathol; 2000 May; 13(5):495-501. PubMed ID: 10824920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC2 is a molecular marker for pseudomyxoma peritonei.
    O'Connell JT; Hacker CM; Barsky SH
    Mod Pathol; 2002 Sep; 15(9):958-72. PubMed ID: 12218214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appendiceal mucinous tumors and pseudomyxoma peritonei: histologic features, diagnostic problems, and proposed classification.
    Pai RK; Longacre TA
    Adv Anat Pathol; 2005 Nov; 12(6):291-311. PubMed ID: 16330927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review.
    Bradley RF; Stewart JH; Russell GB; Levine EA; Geisinger KR
    Am J Surg Pathol; 2006 May; 30(5):551-9. PubMed ID: 16699309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei).
    Moran B; Baratti D; Yan TD; Kusamura S; Deraco M
    J Surg Oncol; 2008 Sep; 98(4):277-82. PubMed ID: 18726894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomyxoma peritonei (mucinous carcinoma peritonei) preceded by intraductal papillary neoplasm of the bile duct.
    Jhuang JY; Hsieh MS
    Hum Pathol; 2012 Jul; 43(7):1148-52. PubMed ID: 22406366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review: Pathology and Its Clinical Relevance of Mucinous Appendiceal Neoplasms and Pseudomyxoma Peritonei.
    Legué LM; Creemers GJ; de Hingh IHJT; Lemmens VEPP; Huysentruyt CJ
    Clin Colorectal Cancer; 2019 Mar; 18(1):1-7. PubMed ID: 30611664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomyxoma peritonei.
    Sugarbaker PH
    Cancer Treat Res; 1996; 81():105-19. PubMed ID: 8834579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors.
    Prayson RA; Hart WR; Petras RE
    Am J Surg Pathol; 1994 Jun; 18(6):591-603. PubMed ID: 8179074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome.
    Pestieau SR; Esquivel J; Sugarbaker PH
    Ann Surg Oncol; 2000 Apr; 7(3):199-203. PubMed ID: 10791850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.